1-200649110-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001031725.6(DDX59):āc.1431A>Gā(p.Ser477Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.963 in 1,566,354 control chromosomes in the GnomAD database, including 726,481 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.95 ( 69311 hom., cov: 32)
Exomes š: 0.96 ( 657170 hom. )
Consequence
DDX59
NM_001031725.6 synonymous
NM_001031725.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.22
Genes affected
DDX59 (HGNC:25360): (DEAD-box helicase 59) Predicted to enable RNA binding activity and RNA helicase activity. Predicted to be located in cytoplasm and nucleus. Predicted to be integral component of membrane. Implicated in orofaciodigital syndrome V. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-200649110-T-C is Benign according to our data. Variant chr1-200649110-T-C is described in ClinVar as [Benign]. Clinvar id is 1255474.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.22 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDX59 | NM_001031725.6 | c.1431A>G | p.Ser477Ser | synonymous_variant | 6/8 | ENST00000331314.11 | NP_001026895.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDX59 | ENST00000331314.11 | c.1431A>G | p.Ser477Ser | synonymous_variant | 6/8 | 1 | NM_001031725.6 | ENSP00000330460.6 |
Frequencies
GnomAD3 genomes AF: 0.954 AC: 145122AN: 152138Hom.: 69257 Cov.: 32
GnomAD3 genomes
AF:
AC:
145122
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.967 AC: 205431AN: 212522Hom.: 99321 AF XY: 0.967 AC XY: 112461AN XY: 116288
GnomAD3 exomes
AF:
AC:
205431
AN:
212522
Hom.:
AF XY:
AC XY:
112461
AN XY:
116288
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.964 AC: 1363194AN: 1414098Hom.: 657170 Cov.: 44 AF XY: 0.964 AC XY: 677754AN XY: 702782
GnomAD4 exome
AF:
AC:
1363194
AN:
1414098
Hom.:
Cov.:
44
AF XY:
AC XY:
677754
AN XY:
702782
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.954 AC: 145234AN: 152256Hom.: 69311 Cov.: 32 AF XY: 0.957 AC XY: 71256AN XY: 74446
GnomAD4 genome
AF:
AC:
145234
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
71256
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3417
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Orofaciodigital syndrome V Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at